PS ] showed significant prion strain specificity, which could be related to variation in Sup35 prion structure. Our results imply that homologs of these chaperones may be active against mammalian prion and amyloid diseases.
Results and discussion
The genetic system for detection of [PSI + ] phenotype in the strains used here includes ade2-1 UAA nonsense mutation and SUQ5 (SUP16) tRNA suppressor, which suppresses ade2-1 only in combination with [ [3, 4] . In vitro, Hsp104, Ssa1 and Ydj1 acted together to reactivate aggregated denatured proteins [6] . It has been shown previously that [PSI + ] strains have increased tolerance to heat shock, which could reflect increased levels of stress proteins as a result of translational readthrough [7] . We tested the levels of Ssa, Ssb, Ydj1 and Hsp104 by western dot blotting in all studied strains and their [psi -] variants. Antibodies to Ssa1 and Ssb1 respectively recognized all four Ssa or both Ssb proteins. No significant dependence on [PSI + ] was found, which agrees with the earlier data for Hsp104, Hsp70 and Hsp26 [7] . The increase in the levels of chaperones as a result of their multicopy expression varied greatly for different chaperones (Table 1) . Similar data were obtained for the transformants of [PSI + PS ] 1 and [psi -] strains. Ssa was increased only 1.5-fold, which agrees with the earlier data, relating this to tight autoregulation of the Ssa protein family [4, 8] . A twofold increase in Ssb suggests a similar mechanism for Ssb proteins, whereas the 30-fold increase in Hsp104 indicates lack of autoregulation. Ydj1 showed intermediate ninefold induction. The Ydj1 level was about one half of normal in transformants overexpressing Ssa1 alone, and three times normal upon overexpression of both Ydj1 and Ssa1. This represents a 67% reduction in comparison with the ninefold increase in Ydj1 level upon overexpression of Ydj1 only. The level of Hsp104 did not significantly depend on overexpression of other chaperones, except for Ssb1, which reduced Hsp104 to 70 ± 15% of normal. This suggests that the effects of novel prioncuring chaperones were independent of the known Hsp104 mechanism. In the case of Ssb1 overexpression, the decrease of Hsp104 was also unlikely to cause the [PSI + ] loss, because, as we observed, the loss was not affected by Hsp104 overproduction. The chaperones studied showed different specificity for curing prion strains, the only exception being the Ssa1 Ydj1 pair. Furthermore, simultaneous overexpression of Ssa1 and Ydj1 cured [PSI + PS ] much more efficiently than either alone. This agrees with earlier findings that Ydj1 acts as an Ssa1 partner, increasing its efficiency in vitro [9] . The remarkably different curing specificities of chaperones can hardly be explained by possible variation in their expression. More probably, they reflect the specificity of chaperone interactions with the prion strains. The sensitivity of prion strains to chaperones is likely to depend on such factors as the efficiency of prion recognition by chaperones and the ability of prions to withstand a particular chaperone activity. Chaperones are believed to recognize exposed hydrophobic fragments of misfolded proteins, which should normally be buried inside protein molecules. The amount of such fragments and, therefore, the recognition efficiency should vary depending on the prion strain-specific folding. The primary structure of the prion domain The efficiency of prion curing for the strains presented in Figure 1 and for 'strong' [PSI + ] was interpreted as follows: -, no curing; ±, inefficient curing; +, noticeable curing; ++, efficient curing; +++, (almost) complete curing. +*, the majority of these transformants were strongly inhibited for growth and did not lose [PSI + PS ], whereas larger red-sectored colonies represented the minority. At least 100 transformants were studied for each combination of strain and chaperone. Each transformation was repeated at least twice. † Increase in levels of the indicated chaperones in the lysates of [PSI + PS ] 1 transformants overexpressing these chaperones compared with the control lysate, as determined by densitometry of western dot blots of sequentially diluted lysates. The standard error did not exceed 20%. The blots were developed using the ECL system (Amersham). The strains were characterized for the level of UAA readthrough (an average of three independent measurements) in the absence of excess chaperones. The UAA readthrough for 5V-H19 [psi -] was 2.3 ± 0.5% and for [psi -PS ] was 2.8 ± 0.7%.
could also modulate the recognition efficiency. Kinetic parameters such as prion polymerization speed should also depend on folding and influence the resistance of prions to chaperones. Therefore, a prion fold could define the sensitivity of prions to chaperones in many ways.
The above considerations suggest an explanation for the observation that [PSI + PS ] is more resistant to Hsp104 overexpression than [PSI + ]. We have proposed that Sup35 prion aggregates represent amyloid-like fibers, which are fragmented by Hsp104 [10] . Higher Hsp104 levels result in smaller fragments, and curing would occur when they become too small to seed polymerization. Prion conversion and polymerization should occur only at the ends of fibers, so the overall conversion rate is a product of polymerization speed and number of fibers. Two [PSI + ] strains with similar suppressor efficiency should have similar levels of soluble Sup35 and a similar prion conversion rate. Given this, one strain may have a higher polymerization speed, but fewer prion particles than the other. Apparently, such a prion is recognized less well by Hsp104 and should be more resistant to Hsp104 overproduction. The properties of [PSI + PS ] resemble this case. In addition to higher Hsp104 resistance, their lower mitotic stability may be related to the presence of fewer prion particles and the Sup35PS prion particles appear to sediment faster than that of Sup35 [5] .
Ssb proteins are functionally distinct from Ssa despite their 60% sequence similarity. It is not clear what causes the different prion-curing properties of Ssa1 and Ssb1. The model mentioned [10] suggests two routes for prion curing: either to break prion particles, as proposed for Hsp104, or to interfere with polymerization. The lack of synergistic effects of overexpression of Hsp104 with other chaperones suggests that their involvement is not critical for the first route. More likely, they act through the second route, by binding to the growth-competent surfaces of prion polymers or to imperfectly folded monomers of prion protein. Ssa1 has been reported to inhibit [PSI + ] curing by excess Hsp104 [4] . In contrast, we observed that overproduction of Ssa1 caused either prion curing or no effects depending on the prion strain and origin of the prion domain. Thus, the earlier data represent a particular case of a more general situation that Ssa1 can exert opposite effects on prion propagation, depending on the prion. [11, 12] . Therefore, different sets of chaperones may be active in curing different prions and, as we observed here, even different strains of the same prion. We therefore suggest that the prion-curing potential of Ssa1, Ssb1 and Ydj1 is not restricted to [PSI + PS ], but represents a more general case.
The properties of yeast prions suggest that they are fundamentally similar not only to mammalian prions, but also to amyloids. Like amyloidogenic proteins, Sup35 assembled in vitro into uniform fibers which showed the key properties of amyloids [13] . Both prions and amyloids use an autocatalytic mechanism of conformational rearrangement. Therefore, yeast prions may be a convenient model for finding factors active against human prion and amyloid diseases. The anti-prion effect of Ssa1, Ssb1 and Ydj1 suggests that their human homologs could act as such factors. Such homologs with high similarity levels of 74% (Ssa1), 61% (Ssb1) and 48% (Ydj1) are present in humans. In contrast, no good homolog for Hsp104 has yet been found in humans or in metazoa in general, including the completely sequenced genomes of Caenorhabditis elegans and Drosophila melanogaster (by BLAST search at http://www.ncbi.nlm.nih.gov/BLAST/). The validity of this approach was confirmed by recent data that the overexpression of human Ydj1 homologs HDJ-1 and HDJ-2 in mammalian cells suppressed the aggregation and toxicity of ataxin-3 with expanded polyglutamine tract [14] . Overexpression of HSP70 in Drosophila suppressed neurodegeneration associated with expanded ataxin-3, although it did not prevent its aggregation [15] . A more systematic search may reveal additional factors that influence prion propagation in yeast and could be used as tools for treatment of human amyloidoses.
Materials and methods
The yeast strains used were 5V-H19 a ade2-1 SUQ5 ura3-52 leu2-3,112 can1-100 [PSI + ] and its derivative PS-5V-H19 [PSI + PS ], which expresses hybrid Sup35 with a prion domain from P. methanolica as a result of an altered chromosomal SUP35 locus [5] . Standard rich (YPD) and synthetic (SC) media were used for yeast growth [16] . Transformations with multicopy LEU2 plasmids pRS425-SSA1, pRS425-SSA1YDJ1, Yeplac181-YDJ1, pFL46-SSB1, pFL46-SSB1YDJ1 and multicopy URA3 plasmid pFL44-HSP104 were performed as described [17] . pRS425-SSA1 and pRS313-YDJ1 were a kind gift of S. Lindquist. An Eco72I-Sal I fragment carrying the YDJ1 gene was isolated from pRS313-YDJ1 and cloned into Yeplac181, pRS425-SSA1 and pFL46-SSB1. pFL46-SSB1 and pFL44-HSP104 are clones from the yeast genomic library (M.B., unpublished data). The UAA nonsense suppression levels were determined by measuring the β-galactosidase activity in cells transformed with pUKC815 and pUKC817 plasmids as described [18] . These plasmids encode a fusion of the 5′ part of the PGK1 gene and the lacZ gene, with a UAA codon inserted at their junction in pUKC817.
